- Previous Close
0.0285 - Open
0.0499 - Bid 0.0300 x --
- Ask 0.0400 x --
- Day's Range
0.0499 - 0.0499 - 52 Week Range
0.0499 - 0.0499 - Volume
23,874 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) 1.86
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.
www.petvivo.comRecent News: PETVW
View MoreCompare To: PETVW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PETVW
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-159.92%
Return on Equity (ttm)
-8,616.61%
Revenue (ttm)
956.05k
Net Income Avi to Common (ttm)
-8.63M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
28.89k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.42M